Where is OneQor located?

OneQor is headquartered in Phoenix, United States.

How many employees does OneQor have?

As of Jul 01, 2024, the latest employee count at OneQor is 3.

Is OneQor a funded company?

OneQor is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does OneQor rank among its competitors?

OneQor ranks 180th amongst 238 active competitors, of which 27 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was ZYUS Life Sciences, which secured $207K in Mar, 2026.

Who are the top competitors of OneQor?

OneQor's top competitors include Sanity Group, ZYUS Life Sciences and gLeaf. Among them, ZYUS Life Sciences secured the most recent funding round in March, 2026.

OneQor - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of cannabis-based pharmaceuticals products for medical solutions. The company is developing proprietary cannabinoids for the use in precision medicine.

Website: oneqor.com
Social
Email ID: *****@oneqor.com

Key Metrics

Founded Year

2018

Location

Phoenix, United States

Stage

Funding Raised

Investors

Keneh Ventures

Ranked

180^th among 238 active competitors

Employee Count

3 as on Jul 01, 2024

Similar Companies

Sanity Group & 289 more

View OneQor's full profile

OneQor is a funded company. OneQor has 1 institutional investor.

View details of OneQor's funding rounds and investors

OneQor's employee count trend

OneQor has 3 employees as of Jul 24. Here is OneQor's employee count trend over the years:

Uncover OneQor's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of OneQor include Sanity Group, ZYUS Life Sciences and gLeaf. Here is the list of Top 10 competitors of OneQor, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Sanity Group 2011, Berlin (Germany), Acquired	Developer of cannabinoid-based pharmaceuticals and well-being products	$109M	HV Capital, TQ Ventures & 18 others	67/100
2nd	ZYUS Life Sciences 2018, Saskatoon (Canada), Public	Developer of cannabis-derived therapeutics for multiple indications	$19.5M	Keyhorse Capital, Mammoth View	58/100
3rd	gLeaf 2014, Frederick (United States), Acquired	Medical cannabis cultivator	$19.4M	Chicago Atlantic	56/100
4th	BOHECO 2013, Mumbai (India), Seed	Provider of cannabis-derived nutritional and wellness products	$9.53M	S R B Buildtech LLP, 1270967 B. C. Ltd & 33 others	56/100
5th	Grow Group 2017, London (United Kingdom), Series C	Developer of cannabis-based medicines for multiple indications	$12.6M	-	54/100
6th	Avicanna 2016, Toronto (Canada), Public	Developer of plant-derived cannabinoid-based products	$5.94M	Barn Invest, Orthogonal Thinker & 1 others	52/100
7th	IMCannabis 2008, Herzliya (Israel), Public	Developer of medical cannabis products	-	-	51/100
8th	Creso Pharma 2015, Perth (Australia), Acquired	Developer of cannabinoid therapeutics for multiple health purposes	-	EverBlu Capital, L1 Capital	50/100
9th	Neocannbio 2021, Seoul (South Korea), Series B	Developer of cannabinoid ingredients and natural products for pharmaceutical applications	$10.9M	Prologue, QUAD & 16 others	49/100
10th	Little Green Pharma 2016, Perth (Australia), Public	Manufacturer of medicinal cannabis for therapeutic use	$1.91M	Fastforward Innovations	49/100
180th	OneQor 2018, Phoenix (United States), Funding Raised	Developer of cannabis-based pharmaceuticals products for medical solutions	-	Keneh Ventures	18/100